Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in canines

To investigate the effect of blocking nitric oxide production on cardiovascular function and survival in canine septic shock treated with or without a conventional vasopressor. Randomized, controlled trial. An animal research laboratory at the National Institutes of Health. Sixty purpose-bred beagle...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Critical care medicine 1998-05, Vol.26 (5), p.877-886
Hauptverfasser: Freeman, B D, Zeni, F, Banks, S M, Eichacker, P Q, Bacher, J D, Garvey, E P, Tuttle, J V, Jurgensen, C H, Natanson, C, Danner, R L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 886
container_issue 5
container_start_page 877
container_title Critical care medicine
container_volume 26
creator Freeman, B D
Zeni, F
Banks, S M
Eichacker, P Q
Bacher, J D
Garvey, E P
Tuttle, J V
Jurgensen, C H
Natanson, C
Danner, R L
description To investigate the effect of blocking nitric oxide production on cardiovascular function and survival in canine septic shock treated with or without a conventional vasopressor. Randomized, controlled trial. An animal research laboratory at the National Institutes of Health. Sixty purpose-bred beagles. Fibrin clots containing Escherichia coli were surgically placed into the peritoneal cavity. N(omega)-monomethyl-L-arginine (L-NMMA) 10 mg/kg followed by 0.5, 1.0, or 4.0 mg/kg/hr), epinephrine (1 microg/kg/min), both, or neither were infused for 24 hrs beginning 6 hrs after the onset of infection. All animals received fluid and antibiotic therapy. Serum nitric oxide metabolites, nitrite and nitrate, increased with infection (p = .024) and decreased with L-NMMA (p = .004, all doses combined). Myocardial nitric oxide synthase activity was ranked as follows: nonsurvivors > survivors > noninfected controls (p < .01). Other tissues examined showed the same pattern. L-NMMA produced sustained increases in systemic vascular resistance index and mean arterial pressure 9 and 24 hrs after the onset of infection (p < or = .04). Left ventricular ejection fraction was depressed by septic shock (p = .01) and further decreased by L-NMMA (p = .02). However, control and L-NMMA cardiac index values were similar (p > .4), perhaps because L-NMMA increased pulmonary artery occlusion pressure (p = .02). From 9 to 24 hrs, epinephrine, in the absence or presence of L-NMMA, blunted recovery of cardiac index (p < .02) and had a diminishing vasopressor effect (p = .05). Neither L-NMMA nor epinephrine, individually or combined, significantly altered survival rates at the doses investigated (p > or = .69). The tested doses showed that nitric oxide production was inhibited by L-NMMA in canine septic shock, but mortality and myocardial depression were unaffected. These results suggest that if L-NMMA has a beneficial effect on survival rates in septic shock, it is small.
doi_str_mv 10.1097/00003246-199805000-00022
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_79875329</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79875329</sourcerecordid><originalsourceid>FETCH-LOGICAL-p123t-dcffc1af17f727bf0a0bef27fb80f96ee06993fe70f1876f8f19a2c5de28ad783</originalsourceid><addsrcrecordid>eNotkE1LxDAQhnNQ1nX1Jwg5iR6i-dg2zVEWv2BRED2XtJ1sK20Sk1TZq7_cFndgmPflfRiYQQgzesOokrd0KsHXOWFKFTSbHJma8yO0pFRRItZKnKDTGD8pZetMigVaqExRwYol-n2D6J2NgJ3BqQUcwaeuxt861mOv0xgAJ4d9cL2zO2jmwPkAMbow80H7Pf7pUotfrtwAO31NBmcnldp9T7ZEh11nOwtY2waDn5Rvw-w7i2s9J_EMHRvdRzg_zBX6eLh_3zyR7evj8-ZuSzzjIpGmNqZm2jBpJJeVoZpWYLg0VUGNygForpQwIKlhhcxNYZjSvM4a4IVuZCFW6PJ_73TM1wgxlUMXa-h7bcGNsZSqkJngagIvDuBYDdCUPnSDDvvy8DTxB4KBch8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79875329</pqid></control><display><type>article</type><title>Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in canines</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Freeman, B D ; Zeni, F ; Banks, S M ; Eichacker, P Q ; Bacher, J D ; Garvey, E P ; Tuttle, J V ; Jurgensen, C H ; Natanson, C ; Danner, R L</creator><creatorcontrib>Freeman, B D ; Zeni, F ; Banks, S M ; Eichacker, P Q ; Bacher, J D ; Garvey, E P ; Tuttle, J V ; Jurgensen, C H ; Natanson, C ; Danner, R L</creatorcontrib><description>To investigate the effect of blocking nitric oxide production on cardiovascular function and survival in canine septic shock treated with or without a conventional vasopressor. Randomized, controlled trial. An animal research laboratory at the National Institutes of Health. Sixty purpose-bred beagles. Fibrin clots containing Escherichia coli were surgically placed into the peritoneal cavity. N(omega)-monomethyl-L-arginine (L-NMMA) 10 mg/kg followed by 0.5, 1.0, or 4.0 mg/kg/hr), epinephrine (1 microg/kg/min), both, or neither were infused for 24 hrs beginning 6 hrs after the onset of infection. All animals received fluid and antibiotic therapy. Serum nitric oxide metabolites, nitrite and nitrate, increased with infection (p = .024) and decreased with L-NMMA (p = .004, all doses combined). Myocardial nitric oxide synthase activity was ranked as follows: nonsurvivors &gt; survivors &gt; noninfected controls (p &lt; .01). Other tissues examined showed the same pattern. L-NMMA produced sustained increases in systemic vascular resistance index and mean arterial pressure 9 and 24 hrs after the onset of infection (p &lt; or = .04). Left ventricular ejection fraction was depressed by septic shock (p = .01) and further decreased by L-NMMA (p = .02). However, control and L-NMMA cardiac index values were similar (p &gt; .4), perhaps because L-NMMA increased pulmonary artery occlusion pressure (p = .02). From 9 to 24 hrs, epinephrine, in the absence or presence of L-NMMA, blunted recovery of cardiac index (p &lt; .02) and had a diminishing vasopressor effect (p = .05). Neither L-NMMA nor epinephrine, individually or combined, significantly altered survival rates at the doses investigated (p &gt; or = .69). The tested doses showed that nitric oxide production was inhibited by L-NMMA in canine septic shock, but mortality and myocardial depression were unaffected. These results suggest that if L-NMMA has a beneficial effect on survival rates in septic shock, it is small.</description><identifier>ISSN: 0090-3493</identifier><identifier>DOI: 10.1097/00003246-199805000-00022</identifier><identifier>PMID: 9590318</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Dogs ; Drug Combinations ; Enzyme Inhibitors - therapeutic use ; Epinephrine - therapeutic use ; Escherichia coli Infections - drug therapy ; Hemodynamics - drug effects ; Nitric Oxide - biosynthesis ; Nitric Oxide - blood ; Nitric Oxide - metabolism ; Nitric Oxide Synthase - antagonists &amp; inhibitors ; Nitric Oxide Synthase - metabolism ; omega-N-Methylarginine - therapeutic use ; Sepsis - drug therapy ; Vasoconstrictor Agents - therapeutic use</subject><ispartof>Critical care medicine, 1998-05, Vol.26 (5), p.877-886</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9590318$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Freeman, B D</creatorcontrib><creatorcontrib>Zeni, F</creatorcontrib><creatorcontrib>Banks, S M</creatorcontrib><creatorcontrib>Eichacker, P Q</creatorcontrib><creatorcontrib>Bacher, J D</creatorcontrib><creatorcontrib>Garvey, E P</creatorcontrib><creatorcontrib>Tuttle, J V</creatorcontrib><creatorcontrib>Jurgensen, C H</creatorcontrib><creatorcontrib>Natanson, C</creatorcontrib><creatorcontrib>Danner, R L</creatorcontrib><title>Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in canines</title><title>Critical care medicine</title><addtitle>Crit Care Med</addtitle><description>To investigate the effect of blocking nitric oxide production on cardiovascular function and survival in canine septic shock treated with or without a conventional vasopressor. Randomized, controlled trial. An animal research laboratory at the National Institutes of Health. Sixty purpose-bred beagles. Fibrin clots containing Escherichia coli were surgically placed into the peritoneal cavity. N(omega)-monomethyl-L-arginine (L-NMMA) 10 mg/kg followed by 0.5, 1.0, or 4.0 mg/kg/hr), epinephrine (1 microg/kg/min), both, or neither were infused for 24 hrs beginning 6 hrs after the onset of infection. All animals received fluid and antibiotic therapy. Serum nitric oxide metabolites, nitrite and nitrate, increased with infection (p = .024) and decreased with L-NMMA (p = .004, all doses combined). Myocardial nitric oxide synthase activity was ranked as follows: nonsurvivors &gt; survivors &gt; noninfected controls (p &lt; .01). Other tissues examined showed the same pattern. L-NMMA produced sustained increases in systemic vascular resistance index and mean arterial pressure 9 and 24 hrs after the onset of infection (p &lt; or = .04). Left ventricular ejection fraction was depressed by septic shock (p = .01) and further decreased by L-NMMA (p = .02). However, control and L-NMMA cardiac index values were similar (p &gt; .4), perhaps because L-NMMA increased pulmonary artery occlusion pressure (p = .02). From 9 to 24 hrs, epinephrine, in the absence or presence of L-NMMA, blunted recovery of cardiac index (p &lt; .02) and had a diminishing vasopressor effect (p = .05). Neither L-NMMA nor epinephrine, individually or combined, significantly altered survival rates at the doses investigated (p &gt; or = .69). The tested doses showed that nitric oxide production was inhibited by L-NMMA in canine septic shock, but mortality and myocardial depression were unaffected. These results suggest that if L-NMMA has a beneficial effect on survival rates in septic shock, it is small.</description><subject>Animals</subject><subject>Dogs</subject><subject>Drug Combinations</subject><subject>Enzyme Inhibitors - therapeutic use</subject><subject>Epinephrine - therapeutic use</subject><subject>Escherichia coli Infections - drug therapy</subject><subject>Hemodynamics - drug effects</subject><subject>Nitric Oxide - biosynthesis</subject><subject>Nitric Oxide - blood</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide Synthase - antagonists &amp; inhibitors</subject><subject>Nitric Oxide Synthase - metabolism</subject><subject>omega-N-Methylarginine - therapeutic use</subject><subject>Sepsis - drug therapy</subject><subject>Vasoconstrictor Agents - therapeutic use</subject><issn>0090-3493</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNotkE1LxDAQhnNQ1nX1Jwg5iR6i-dg2zVEWv2BRED2XtJ1sK20Sk1TZq7_cFndgmPflfRiYQQgzesOokrd0KsHXOWFKFTSbHJma8yO0pFRRItZKnKDTGD8pZetMigVaqExRwYol-n2D6J2NgJ3BqQUcwaeuxt861mOv0xgAJ4d9cL2zO2jmwPkAMbow80H7Pf7pUotfrtwAO31NBmcnldp9T7ZEh11nOwtY2waDn5Rvw-w7i2s9J_EMHRvdRzg_zBX6eLh_3zyR7evj8-ZuSzzjIpGmNqZm2jBpJJeVoZpWYLg0VUGNygForpQwIKlhhcxNYZjSvM4a4IVuZCFW6PJ_73TM1wgxlUMXa-h7bcGNsZSqkJngagIvDuBYDdCUPnSDDvvy8DTxB4KBch8</recordid><startdate>199805</startdate><enddate>199805</enddate><creator>Freeman, B D</creator><creator>Zeni, F</creator><creator>Banks, S M</creator><creator>Eichacker, P Q</creator><creator>Bacher, J D</creator><creator>Garvey, E P</creator><creator>Tuttle, J V</creator><creator>Jurgensen, C H</creator><creator>Natanson, C</creator><creator>Danner, R L</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>199805</creationdate><title>Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in canines</title><author>Freeman, B D ; Zeni, F ; Banks, S M ; Eichacker, P Q ; Bacher, J D ; Garvey, E P ; Tuttle, J V ; Jurgensen, C H ; Natanson, C ; Danner, R L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p123t-dcffc1af17f727bf0a0bef27fb80f96ee06993fe70f1876f8f19a2c5de28ad783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Animals</topic><topic>Dogs</topic><topic>Drug Combinations</topic><topic>Enzyme Inhibitors - therapeutic use</topic><topic>Epinephrine - therapeutic use</topic><topic>Escherichia coli Infections - drug therapy</topic><topic>Hemodynamics - drug effects</topic><topic>Nitric Oxide - biosynthesis</topic><topic>Nitric Oxide - blood</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide Synthase - antagonists &amp; inhibitors</topic><topic>Nitric Oxide Synthase - metabolism</topic><topic>omega-N-Methylarginine - therapeutic use</topic><topic>Sepsis - drug therapy</topic><topic>Vasoconstrictor Agents - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Freeman, B D</creatorcontrib><creatorcontrib>Zeni, F</creatorcontrib><creatorcontrib>Banks, S M</creatorcontrib><creatorcontrib>Eichacker, P Q</creatorcontrib><creatorcontrib>Bacher, J D</creatorcontrib><creatorcontrib>Garvey, E P</creatorcontrib><creatorcontrib>Tuttle, J V</creatorcontrib><creatorcontrib>Jurgensen, C H</creatorcontrib><creatorcontrib>Natanson, C</creatorcontrib><creatorcontrib>Danner, R L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Freeman, B D</au><au>Zeni, F</au><au>Banks, S M</au><au>Eichacker, P Q</au><au>Bacher, J D</au><au>Garvey, E P</au><au>Tuttle, J V</au><au>Jurgensen, C H</au><au>Natanson, C</au><au>Danner, R L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in canines</atitle><jtitle>Critical care medicine</jtitle><addtitle>Crit Care Med</addtitle><date>1998-05</date><risdate>1998</risdate><volume>26</volume><issue>5</issue><spage>877</spage><epage>886</epage><pages>877-886</pages><issn>0090-3493</issn><abstract>To investigate the effect of blocking nitric oxide production on cardiovascular function and survival in canine septic shock treated with or without a conventional vasopressor. Randomized, controlled trial. An animal research laboratory at the National Institutes of Health. Sixty purpose-bred beagles. Fibrin clots containing Escherichia coli were surgically placed into the peritoneal cavity. N(omega)-monomethyl-L-arginine (L-NMMA) 10 mg/kg followed by 0.5, 1.0, or 4.0 mg/kg/hr), epinephrine (1 microg/kg/min), both, or neither were infused for 24 hrs beginning 6 hrs after the onset of infection. All animals received fluid and antibiotic therapy. Serum nitric oxide metabolites, nitrite and nitrate, increased with infection (p = .024) and decreased with L-NMMA (p = .004, all doses combined). Myocardial nitric oxide synthase activity was ranked as follows: nonsurvivors &gt; survivors &gt; noninfected controls (p &lt; .01). Other tissues examined showed the same pattern. L-NMMA produced sustained increases in systemic vascular resistance index and mean arterial pressure 9 and 24 hrs after the onset of infection (p &lt; or = .04). Left ventricular ejection fraction was depressed by septic shock (p = .01) and further decreased by L-NMMA (p = .02). However, control and L-NMMA cardiac index values were similar (p &gt; .4), perhaps because L-NMMA increased pulmonary artery occlusion pressure (p = .02). From 9 to 24 hrs, epinephrine, in the absence or presence of L-NMMA, blunted recovery of cardiac index (p &lt; .02) and had a diminishing vasopressor effect (p = .05). Neither L-NMMA nor epinephrine, individually or combined, significantly altered survival rates at the doses investigated (p &gt; or = .69). The tested doses showed that nitric oxide production was inhibited by L-NMMA in canine septic shock, but mortality and myocardial depression were unaffected. These results suggest that if L-NMMA has a beneficial effect on survival rates in septic shock, it is small.</abstract><cop>United States</cop><pmid>9590318</pmid><doi>10.1097/00003246-199805000-00022</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0090-3493
ispartof Critical care medicine, 1998-05, Vol.26 (5), p.877-886
issn 0090-3493
language eng
recordid cdi_proquest_miscellaneous_79875329
source MEDLINE; Journals@Ovid Complete
subjects Animals
Dogs
Drug Combinations
Enzyme Inhibitors - therapeutic use
Epinephrine - therapeutic use
Escherichia coli Infections - drug therapy
Hemodynamics - drug effects
Nitric Oxide - biosynthesis
Nitric Oxide - blood
Nitric Oxide - metabolism
Nitric Oxide Synthase - antagonists & inhibitors
Nitric Oxide Synthase - metabolism
omega-N-Methylarginine - therapeutic use
Sepsis - drug therapy
Vasoconstrictor Agents - therapeutic use
title Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in canines
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A51%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Response%20of%20the%20septic%20vasculature%20to%20prolonged%20vasopressor%20therapy%20with%20N(omega)-monomethyl-L-arginine%20and%20epinephrine%20in%20canines&rft.jtitle=Critical%20care%20medicine&rft.au=Freeman,%20B%20D&rft.date=1998-05&rft.volume=26&rft.issue=5&rft.spage=877&rft.epage=886&rft.pages=877-886&rft.issn=0090-3493&rft_id=info:doi/10.1097/00003246-199805000-00022&rft_dat=%3Cproquest_pubme%3E79875329%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79875329&rft_id=info:pmid/9590318&rfr_iscdi=true